AACC 2011 New Immunoassay Product Launches from Tosoh

Share Article

Tosoh Bioscience, Inc. will be launching new products for immunoassay testing at the 2011 AACC Annual Meeting and Clinical Lab Expo in Atlanta, Georgia from July 24 to 28 (Booth #401).

2011 AACC Annual Meeting and Clinical Lab Expo in Atlanta New Product Launch

AACC 2011 New Product Launch from Tosoh Bioscience

2011 AACC Annual Meeting in Atlanta will mark the official launch of Tosoh's AIA-900 Immunoassay Analyzer

Tosoh Bioscience, Inc. will be launching new products for immunoassay testing at the 2011 AACC Annual Meeting and Clinical Lab Expo in Atlanta, Georgia from July 24 to 28 (Booth #401).

Tosoh’s next generation system, the AIA-900 Automated Immunoassay Analyzer, features three system configurations; the AIA-900, the AIA-900 with the 9 tray sorter, and the AIA-900 with the 19 tray sorter. The 3 configurations present customers with a unique opportunity to grow with their testing volumes. Running 90 tests per hour, the analyzer’s user-friendly operations provide extremely efficient immunoassay diagnostics. The AIA-900 utilizes the same Unit Dose Test Cup reagent technology as all Tosoh AIA immunoassay analyzers; and is being launched with the full AIA-Test Menu*.

At AACC 2011, Tosoh will be introducing two new assays: ACTH** and DHEA-S**. Tosoh has also launched HbA1c and Cystatin C earlier this year. These assays all utilize Tosoh’s Unit Dose Test Cup reagent technology, featuring 90-day calibration stability and assay time of approximately 20 minutes.

Tosoh’s powerful AIA-2000 Automated Immunoassay Analyzer delivers 200 results per hour with expanded functionality designed to increase workflow and minimize operator time. For low volume testing, the AIA-360 Automated Immunoassay Analyzer runs 36 tests per hour in an extremely compact footprint, providing a cost efficient solution for immunoassay testing.

For more information contact Tosoh Bioscience at (800) 248-6764 or visit
http://www.diagnostics.us.tosohbioscience.com/

*Pending FDA clearance for ST AIA-PACK PA
** Pending FDA clearance

Tosoh Bioscience, Inc. (TBI) provides highly sophisticated diagnostic systems for immunoassay and HPLC testing to doctor's offices, hospitals and reference laboratories throughout the Americas. Based in South San Francisco, CA, TBI is a U.S. subsidiary of Tosoh Corporation which is headquartered in Tokyo, Japan. TBI is part of Tosoh Corporation's Bioscience Division.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael McHugh
Tosoh
(650) 636 8124
Email >
Visit website